Nonbacterial prostatitis in kunming mouse induced by long-term stimuli of passive sexual abstinence

Journal of Andrology

Volumn 31, Issue 3, 2010, Pages 244-249

  Lv, Chen ^a   Zhong, Zhaohui ^a   Wu, Zhiping ^a   Xiao, Ning ^a   Yang, Minggen ^a   Zhao, Xiaokun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Prostate

Indexed keywords

PROSTATE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPULATION; IMMUNE RESPONSE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATITIS; SEXUAL BEHAVIOR; WEIGHT CHANGE; ANATOMY AND HISTOLOGY; ANIMAL; PATHOLOGY; PHYSIOLOGY; PROSTATE; SEXUAL ABSTINENCE;

ANIMALS; COPULATION; MALE; MICE; PROSTATE; PROSTATITIS; SEXUAL ABSTINENCE;

EID: 77954914722     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.109.007559     Document Type: Article

References (36)

1. Aronsson A, Dahlgren S, Gatenbeck L, Stromberg L. Predictive sites of inflammatory manifestation in the prostatic gland: an experimental study on nonbacterial prostatitis in the rat. Prostate. 1988;13:17-24.
2. Badalyan RR, Fanarjyan SV, Aghajanyan IG. Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitis. Andrologia. 2003;35:263-265.
3. Batstone GR, Doble A, Gaston JS. Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Exp Immunol. 2002;128:302-307.
4. Catt KJ, Harwood JP, Clayton RN, Davies TF, Chan V, Katikineni M, Nozu K, Dufau ML. Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog Hormone Res. 1980;36:557-622.
5. Cheah PY, Liong HL, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN. Chronic prostatitis: symptom survey with follow-up clinical evaluation. Urology. 2003;61:60-64.
6. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224-1228.
7. de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41:301-307.
8. Finkelstein JS, Whitcomb RW, O'Dea LSL, Longcope C, Schoenfeld DA, Crowley JR. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991;73:609-620.
9. Heyns W, Moor P. Prostatic binding protein - a steroid-binding protein secreted by rat prostate. Eur J Biochem. 1977;78:221-230. (Pubitemid 8164741)
10. Jang TL, Schaeffer AJ. The role of cytokines in prostatitis. World J Urol. 2003;21:95-99.
11. John H, Maake C, Barghorn A, Zbinden R, Hauri D, Joller-Jemelka HI. Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity. Andrologia. 2003;35:294-299.
12. Kaplan L, Lee C, Schaeffer AJ. Effect of castration on experimental bacterial prostatitis in rats. Prostate. 1983;4:625-630.
13. Keenan DM, Veldhuis JD. A biomathematical model of time-delayed feedback in the human male hypothalamic-pituitary-Leydig cell axis. Am J Physiol Endocrinol Metab. 1998;275(1):157-176.
14. Keetch DW, Humphrey P, Ratliff TL. Development of a mouse model for nonbacterial prostatitis. J Urol. 1994;152:247-250.
15. Kirby RS, Lowe D, Bultitude MI, Shuttleworth KE. Intraprostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol. 1982;54:729-731.
16. Klyushnenkova EN, Link J, Oberle WT, Kodak J, Rich C, Vandenbark AA, Alexander RB. Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen. Clin Cancer Res. 2005;11:2853-2861.
17. Kunishima Y, Matsukawa M, Takahashi S, Itoh N, Hirose T, Furuya S, Takatsuka K, Mori M, Tsukamoto T. National institutes of health chronic prostatitis symptom index for Japanese men. Urology. 2002;60:74-77.
18. Kwon SM, Kim SI, Chun DC, Cho NH, Chung BC, Park BW, Hong SJ. Development of rat prostatitis model by oral administration of isoflavone and its characteristics. Yonsei Med J. 2001;42:395-404.
19. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, Gupta S. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. J Urol. 2006;176:1012-1016.
20. Meares EM. Nonbacterial prostatitis and prostatodynia. In: Lepor H, Lawson RK, eds. Prostate Disease. 1st ed. Philadelphia, PA: WB Saunders Company; 1993:419-424.
21. Mehik A, Hellstrom P, Lukkarinen O, Sarpola A, Jarvelin M. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. 2000;86:443-448.
22. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL. Nerve growth factor and chronic prostatitis/ chronic pelvic pain syndrome. Urology. 2002;59:603-608.
23. Naslund MJ, Coffey DS. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J Urol. 1986;136:1136-1140.
24. Naslund MJ, Strandberg JD, Coffey DS. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol. 1988;140:1049-1053.
25. Nickel JC. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int. 2004;94:1230-1233.
26. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol. 2001;165:842-845.
27. Nickel JC, Downey J, Pontari MA, Shoskes D, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IHA chronic nonbacterial prostatitis). BJU Int. 2004;93:991-995.
28. Nickel JC, Olson ME, Barabas A, Benediktsson H, Dasgupta MK, Costerton JW. Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol. 1990;66:47-54.
29. Pakarainen T, Zhang FP, Makela S, Poutanen M, Huhtaniemi I. Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice. Endocrinology. 2005;146:596-606.
30. Pavone C, Caldarera E, Liberti P. Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatients. Eur Urol. 2000;37(4):400-403.
31. Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Adorini L. Spontaneous and induced autoimmune prostatitis in the non-obese diabetic mouse. J Urol. 2006;175(suppl):35.
32. Pierroz DD, Aebi CA, Huhtaniemi IT, Aubert ML. Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY. Am J Physiol Endocrinol Metab. 1999;276:603-610.
33. Rivero VE, Cailleau C, Depiante-Depaoli M, Riera CM, Carnaud C. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun. 1998;11:603-610.
34. Rivero VE, Carnaud C, Riera CM. Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice. Clin Immunol. 2002;105:176-184.
35. Robinette CL. Sex hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate. 1988;12:271-286.
36. Young HH, Geraghty JT, Stevens AR. Chronic prostatitis. An experimental and clinical study with an analysis of 358 cases. Johns Hopkins Hosp Rep. 1906;13:271-384.